Squirrel in Colorado Tests Positive for Bubonic Plague

A squirrel in Colorado has tested positive for bubonic plague, according to a posting on the Jefferson County, Colorado, public health site. The squirrel was found in the Town of Morrison, 17 miles southwest of Denver, and is the first cause of plague in the county, according to officials. “Plague is an infectious disease caused by the bacteria Yersinia pestis, and can be contracted by humans and household animals if proper precautions are not taken,” the site warned. Humans can be infected through bites from infected fleas or by the…

Read More

Study: Immune Response Provides Clue Into Why COVID Kills More Older Men

According to a new study, older men are up to twice as likely to become sick and even die from the coronavirus as women of the same age because of their immune response. The study’s findings published Wednesday in Nature indicate men produce a weaker immune response to the virus than woman. According to researchers, men, especially those over the age of 60, might need to depend more on a coronavirus vaccine to protect against the virus. “Natural infection is clearly failing” to create adequate immune responses in men, Akiko…

Read More

Tiny Llama Antibodies Might Offer Hope for COVID Treatment Read Newsmax: Tiny Llama Antibodies Might Offer Hope for COVID Treatment | Newsmax.com Urgent: Your Heart Attack Risk Determined Online – More Info

Llamas have unique antibodies that are so tiny they can bind to the proteins of the coronavirus preventing their spread. Scientists are hoping to harness the power of these antibodies to prevent the virus from infecting humans. According to NBC News, researchers from the University of California in San Francisco developed a molecule in their laboratory using llama antibodies as a model that has proven to be surprising effective in neutralizing the coronavirus. “It binds to the virus’ protein with an unmatched affinity — we’ve never seen anything like this…

Read More

Study: Obesity Increases Risk of COVID-19 Death by Nearly 50 Percent

Obesity increases the risk of coronavirus death by nearly 50 percent, according to a study released Wednesday by the University of North Carolina at Chapel Hill. Additionally, future vaccines may be less effective for the clinically overweight. Researchers at UNC reviewed available data on individuals infected with COVID-19 and found that those with a body mass index over 30 were at a greater risk of hospitalization (113 percent), more likely to be admitted to the intensive care unit (74 percent) and had a higher risk of death (48 percent). “All…

Read More

Almost 3,500 Health Experts Sign Letter Supporting Dr. Fauci

As Dr. Anthony Fauci has become “uninvited” to President Donald Trump solo-act White House coronavirus task force daily briefings, thousands of public health experts have written a letter to express their support for the longtime infectious disease leader. “This week and last, the White House mounted a campaign to discredit one of our nation’s leading scientific experts, Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, who has advised six Presidents on epidemics from HIV to SARS, from Ebola to H1N1 influenza,” a letter from…

Read More

AI Sweeps Human Pilot in DARPA Dogfight Simulation

A human pilot was swept 5-0 in dogfight simulations against artificial intelligence, which is being hailed as a victory for the Defense Advanced Research Projects Agency (DARPA). The goal of the trial was to give pilots confidence in the future of AI commanding combat aircraft, according to Col. Daniel Javorsek, program manager of DARPA’s Air Combat Evolution Program to Air Force Magazine. Even if a couple of pilots gain confidence in the AI algorithm developed by Heron Systems, “then I’m considering it a success,” Col. Javorsek told the magazine. “That’s…

Read More

AstraZeneca Denies Fast-Tracking Vaccine for White House

Pharmaceutical firm AstraZeneca says it has not had any discussions with any U.S. government officials about an emergency use authorization for its coronavirus vaccine, Politico reports. The company’s statement comes a day after the Financial Times reported the White House would consider how to grant an emergency use of the AstraZeneca vaccine if a late-stage clinical trial currently taking place in the U.K. and other countries has positive results. “It would be premature to speculate on that possibility,” the pharmaceutical company said in a statement. The vaccine was developed by…

Read More

54% of internet users think that they were exposed to misinformation about the origin of Covid-19

The spread of misinformation in the society has also accelerated with the novel coronavirus pandemic. According to the study conducted by Teyit, which conducts research on the information ecosystem in Turkey with Tandans Data Science Consultant, more than half of the participants think they were exposed to misinformation about the origin of Covid-19. *** This release is originally published in Turkish. Google Translate Application translates the content you see on this page.*** ISTANBUL (TR) – Since the outbreak of the novel coronavirus in Turkey, the spread of misinformation has accelerated…

Read More

AstraZeneca Denies Fast-Tracking Vaccine for White House

Pharmaceutical firm AstraZeneca says it has not had any discussions with any U.S. government officials about an emergency use authorization for its coronavirus vaccine, Politico reports. The company’s statement comes a day after the Financial Times reported the White House would consider how to grant an emergency use of the AstraZeneca vaccine if a late-stage clinical trial currently taking place in the U.K. and other countries has positive results. “It would be premature to speculate on that possibility,” the pharmaceutical company said in a statement. The vaccine was developed by…

Read More

Abbott Labs Launches 5-Minute Point of Care COVID-19 Test

Abbott Laboratories is unveiling a coronavirus test that can tell if someone is infected in as little as 5 minutes, and is so small and portable it can be used in almost any healthcare setting. The medical-device maker plans to supply 50,000 tests a day starting April 1, said John Frels, vice president of research and development at Abbott Diagnostics. The molecular test looks for fragments of the coronavirus genome, which can be detected in as little as five minutes when it is present at high levels. A thorough search…

Read More